Abstract
Left atrial appendage (LAA), a blind pouch, accounts for more than 90% of the source of cardiac thrombus formation. Contrast retention (CR) in the LAA has been frequently observed during left atrial appendage occlusion (LAAO) procedures, especially in patients with stroke history. This study was designed to assess the relations between LAA contrast retention and thrombogenesis risk of the LAA in patients with non-valvular atrial fibrillation. A total of 132 consecutive patients who underwent LAAO were enrolled. The data collected from computed tomography (CT), transthoracic echocardiography (TTE), transesophageal echocardiography (TEE) and blood samples were analyzed. Univariate and multivariate logistic regression models were constructed to assess the association between CR, left atrial appendage thrombus (LAAT) and other factors. Contrast retention was observed in 33 patients, accounting for 25% of the population. Compared to the non-CR group, patients in the CR group had a larger left atrium anteroposterior diameter (49.64 ± 11.57 vs. 42.42 ± 7.04, P = 0.002), higher CHADS2 (3.88 ± 0.99 vs. 2.97 ± 1.35, P = 0.001) and CHA2DS2-VASc scores (5.79 ± 1.14 vs. 4.89 ± 1.56, P = 0.003), a higher rate of prior stroke (90.9% vs. 66.7%, P = 0.007), more LAA lobes (3.13 ± 1.18 vs. 2.64 ± 1.12, P = 0.038), and a higher prevalence of LAAT (63.6% vs. 13.1%, P < 0.001). After having adjusted the logistic model, only contrast retention, LAA cauliflower morphology and left ventricular ejection fraction (LVEF) were independently associated with LAAT. Patients with LAA contrast retention have a higher risk of left atrial appendage thrombosis. Contrast retention may be a cardiac factor strongly associated with cardiogenic stroke.
Graphic Abstract
Similar content being viewed by others
Data availability
Data are available at https://wws.lanzous.com/iKDO9jjiggd.
Abbreviations
- AF:
-
Atrial fibrillation
- LAA:
-
Left atrial appendage
- CR:
-
Contrast retention
- LAAO:
-
Left atrial appendage occlusion
- LAAT:
-
Left atrial appendage thrombus
- CHADS2 :
-
Congestive heart failure, Hypertension, Age > 75, Diabetes mellitus, and prior Stroke or transient ischemic attack
- CHA2DS2-VASc:
-
Congestive heart failure, Hypertension, Age (> 75 = 2 points, 65 to 74 = 1 point, < 65 = 0 point), Diabetes mellitus, prior Stroke or transient ischemic attack, female gender
- HAS-BLED:
-
Hypertension, Abnormal renal and liver function, Stroke, Bleeding, Labile INRs, Elderly, Drugs or alcohol
- TTE:
-
Transthoracic echocardiography
- TEE:
-
Transesophageal echocardiography
- OR:
-
Odds ratio
- CI:
-
Confidence interval
- TIA:
-
Transient ischemia attack
- LAAPD:
-
Left atria anteroposterior diameter
- CFD:
-
Contrast filling defect
- ROC:
-
Operating characteristic curve
- AUC:
-
Area under the curve
References
Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, Witteman JC, Stricker BH, Heeringa J (2013) Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 34(35):2746–2751. https://doi.org/10.1093/eurheartj/eht280
Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS (2006) Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114(2):119–125. https://doi.org/10.1161/circulationaha.105.595140
Tse HF, Wang YJ, Ahmed Ai-Abdullah M, Pizarro-Borromeo AB, Chiang CE, Krittayaphong R, Singh B, Vora A, Wang CX, Zubaid M, Clemens A, Lim P, Hu D (2013) Stroke prevention in atrial fibrillation–an Asian stroke perspective. Heart Rhythm 10(7):1082–1088. https://doi.org/10.1016/j.hrthm.2013.03.017
Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8):983–988. https://doi.org/10.1161/01.str.22.8.983
Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE (1995) The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98(5):476–484. https://doi.org/10.1016/s0002-9343(99)80348-9
Santangeli P, Di Biase L, Bai R, Mohanty S, Pump A, Cereceda Brantes M, Horton R, Burkhardt JD, Lakkireddy D, Reddy YM, Casella M, Dello Russo A, Tondo C, Natale A (2012) Atrial fibrillation and the risk of incident dementia: a meta-analysis. Heart Rhythm 9(11):1761–1768. https://doi.org/10.1016/j.hrthm.2012.07.026
Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98(10):946–952. https://doi.org/10.1161/01.cir.98.10.946
Thrall G, Lane D, Carroll D, Lip GY (2006) Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 119(5):448.e441–419. https://doi.org/10.1016/j.amjmed.2005.10.057
Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG (1998) Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation: Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol 31(7):1622–1626. https://doi.org/10.1016/s0735-1097(98)00146-6
Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146(12):857–867. https://doi.org/10.7326/0003-4819-146-12-200706190-00007
Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383(9921):955–962. https://doi.org/10.1016/s0140-6736(13)62343-0
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37(38):2893–2962. https://doi.org/10.1093/eurheartj/ehw210
Sikorska A, Baran J, Pilichowska-Paszkiet E, Sikora-Frąc M, Kryński T, Piotrowski R, Stec S, Zaborska B, Kułakowski P (2015) Risk of left atrial appendage thrombus in patients scheduled for ablation for atrial fibrillation: beyond the CHA2DS2VASc score. Pol Arch Med Wewn 125(12):921–928. https://doi.org/10.20452/pamw.3213
Yao Y, Shang MS, Gao LJ, Zhao JH, Yang XH, Liu T, Tang RB, Jiang CX, Long DY, Ning M, Zhu H, Lv Q, Hu R, Du X, Dong JZ (2018) Elevated homocysteine increases the risk of left atrial/left atrial appendage thrombus in non-valvular atrial fibrillation with low CHA2DS2-VASc score. Europace 20(7):1093–1098. https://doi.org/10.1093/europace/eux189
Jaroch J, Kamińska-Kegel A, Brzezińska B, Kruszyńska E, Bociąga Z, Dudek K, Łoboz-Grudzień K (2016) Predictors of left atrial appendage thrombogenic milieu in patients subjected to transesophageal echocardiography prior to cardioversion of persistent atrial fibrillation. Pol Arch Med Wewn 126(1–2):25–31. https://doi.org/10.20452/pamw.3261
Quinn GR, Severdija ON, Chang Y, Singer DE (2017) Wide Variation in Reported Rates of Stroke Across Cohorts of Patients With Atrial Fibrillation. Circulation 135(3):208–219. https://doi.org/10.1161/circulationaha.116.024057
Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263–272. https://doi.org/10.1378/chest.09-1584
Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285(22):2864–2870. https://doi.org/10.1001/jama.285.22.2864
Force CET (1986) Cardiogenic brain embolism: Cerebral Embolism Task Force. Arch Neurol 43(1), 71–84
Blackshear JL, Odell JA (1996) Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 61(2):755–759. https://doi.org/10.1016/0003-4975(95)00887-x
Ren JF, Marchlinski FE, Supple GE, Hutchinson MD, Garcia FC, Riley MP, Lin D, Zado ES, Callans DJ, Ferrari VA (2013) Intracardiac echocardiographic diagnosis of thrombus formation in the left atrial appendage: a complementary role to transesophageal echocardiography. Echocardiography 30(1):72–80. https://doi.org/10.1111/j.1540-8175.2012.01819.x
Hur J, Kim YJ, Lee HJ, Ha JW, Heo JH, Choi EY, Shim CY, Kim TH, Nam JE, Choe KO, Choi BW (2009) Left atrial appendage thrombi in stroke patients: detection with two-phase cardiac CT angiography versus transesophageal echocardiography. Radiology 251(3):683–690. https://doi.org/10.1148/radiol.2513090794
Hur J, Kim YJ, Lee HJ, Nam JE, Hong YJ, Kim HY, Lee JW, Choi BW (2012) Cardioembolic stroke: dual-energy cardiac CT for differentiation of left atrial appendage thrombus and circulatory stasis. Radiology 263(3):688–695. https://doi.org/10.1148/radiol.12111691
Mohrs OK, Nowak B, Petersen SE, Welsner M, Rubel C, Magedanz A, Kauczor HU, Voigtlaender T (2006) Thrombus detection in the left atrial appendage using contrast-enhanced MRI: a pilot study. AJR Am J Roentgenol 186(1):198–205. https://doi.org/10.2214/ajr.04.1504
Ohyama H, Hosomi N, Takahashi T, Mizushige K, Osaka K, Kohno M, Koziol JA (2003) Comparison of magnetic resonance imaging and transesophageal echocardiography in detection of thrombus in the left atrial appendage. Stroke 34(10):2436–2439. https://doi.org/10.1161/01.Str.0000090350.73614.0f
Zhan Y, Joza J, Al Rawahi M, Barbosa RS, Samuel M, Bernier M, Huynh T, Thanassoulis G, Essebag V (2018) Assessment and management of the left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Can J Cardiol 34(3):252–261. https://doi.org/10.1016/j.cjca.2017.12.008
Kapłon-Cieślicka A, Budnik M, Gawałko M, Peller M, Gorczyca I, Michalska A, Babiarz A, Bodys A, Uliński R, Żochowski M, Scisło P, Kochanowski J, Filipiak KJ, Opolski G (2019) Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus. Heart 105(17):1310–1315. https://doi.org/10.1136/heartjnl-2018-314492
Durmaz E, Karpuz MH, Bilgehan K, Ikitimur B, Ozmen E, Ebren C, Polat F, Koca D, Tokdil KO, Kandemirli SG, Atici A, Ongen Z (2020) Left atrial thrombus in patients with atrial fibrillation and under oral anticoagulant therapy; 3-D transesophageal echocardiographic study. Int J Cardiovasc Imaging. https://doi.org/10.1007/s10554-020-01811-x
Oshita T, Mine T, Kishima H, Fukuhara E, Ishihara M (2020) Predictors of movable type left atrial appendage thrombi in patients with atrial fibrillation. Heart Vessels. https://doi.org/10.1007/s00380-020-01589-x
Beigel R, Wunderlich NC, Ho SY, Arsanjani R, Siegel RJ (2014) The left atrial appendage: anatomy, function, and noninvasive evaluation. JACC Cardiovasc Imaging 7(12):1251–1265. https://doi.org/10.1016/j.jcmg.2014.08.009
Beinart R, Heist EK, Newell JB, Holmvang G, Ruskin JN, Mansour M (2011) Left atrial appendage dimensions predict the risk of stroke/TIA in patients with atrial fibrillation. J Cardiovasc Electrophysiol 22(1):10–15. https://doi.org/10.1111/j.1540-8167.2010.01854.x
Tabata T, Oki T, Yamada H, Iuchi A, Ito S, Hori T, Kitagawa T, Kato I, Kitahata H, Oshita S (1998) Role of left atrial appendage in left atrial reservoir function as evaluated by left atrial appendage clamping during cardiac surgery. Am J Cardiol 81(3):327–332. https://doi.org/10.1016/s0002-9149(97)00903-x
Lannigan RA, Zaki SA (1966) Ultrastructure of the myocardium of the atrial appendage. Br Heart J 28(6):796–807. https://doi.org/10.1136/hrt.28.6.796
Yamamoto M, Seo Y, Kawamatsu N, Sato K, Sugano A, Machino-Ohtsuka T, Kawamura R, Nakajima H, Igarashi M, Sekiguchi Y, Ishizu T, Aonuma K (2014) Complex left atrial appendage morphology and left atrial appendage thrombus formation in patients with atrial fibrillation. Circ Cardiovasc Imaging 7(2):337–343. https://doi.org/10.1161/circimaging.113.001317
Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili S, Horton R, Sanchez JE, Bai R, Mohanty S, Pump A, Cereceda Brantes M, Gallinghouse GJ, Burkhardt JD, Cesarani F, Scaglione M, Natale A, Gaita F (2012) Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol 60(6):531–538. https://doi.org/10.1016/j.jacc.2012.04.032
Lee Y, Park HC, Lee Y, Kim SG (2017) Comparison of morphologic features and flow velocity of the left atrial appendage among patients with atrial fibrillation alone, transient ischemic attack, and cardioembolic stroke. Am J Cardiol 119(10):1596–1604. https://doi.org/10.1016/j.amjcard.2017.02.016
Chao TF, Liu CJ, Tuan TC, Chen SJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Chen TJ, Chiang CE, Chen SA (2016) Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: which scoring system should be used for Asians? Heart Rhythm 13(1):46–53. https://doi.org/10.1016/j.hrthm.2015.08.017
Van Staa TP, Setakis E, Di Tanna GL, Lane DA, Lip GY (2011) A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J Thromb Haemost 9(1):39–48. https://doi.org/10.1111/j.1538-7836.2010.04085.x
Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY (2012) The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: a nationwide cohort study. Thromb Haemost 107(6):1172–1179. https://doi.org/10.1160/th12-03-0175
Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials (1998). Arch Intern Med 158(12), 1316–1320. doi:https://doi.org/10.1001/archinte.158.12.1316
Hijazi Z, Lindbäck J, Alexander JH, Hanna M, Held C, Hylek EM, Lopes RD, Oldgren J, Siegbahn A, Stewart RA, White HD, Granger CB, Wallentin L (2016) The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation. Eur Heart J 37(20):1582–1590. https://doi.org/10.1093/eurheartj/ehw054
Mügge A, Kühn H, Nikutta P, Grote J, Lopez JA, Daniel WG (1994) Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. J Am Coll Cardiol 23(3):599–607. https://doi.org/10.1016/0735-1097(94)90743-9
Fatkin D, Kelly RP, Feneley MP (1994) Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 23(4):961–969. https://doi.org/10.1016/0735-1097(94)90644-0
Chan, KL (1998) Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation: the Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Ann Intern Med 128(8), 639–647. doi:https://doi.org/10.7326/0003-4819-128-8-199804150-00005
Doufekias E, Segal AZ, Kizer JR (2008) Cardiogenic and aortogenic brain embolism. J Am Coll Cardiol 51(11):1049–1059. https://doi.org/10.1016/j.jacc.2007.11.053
Acknowledgements
We gratefully acknowledge the neurologist in our hospital for assistance in confirming cardiogenic stroke diagnosis.
Funding
This work was supported by the National Key Research and Development Project of China (grant number 2018YFCZ001200).
Author information
Authors and Affiliations
Contributions
XL collected the data, performed statistical analyses and drafted the manuscript; TC collected data and revised the manuscript; GL and XS participated in collect the data, YC and YC revised the manuscript; YL participated in designing the study and revised the manuscript; JG designed the study, the analyses and revised the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
All the authors declare that they have no conflict of interest.
Ethical approval
The study protocol was approved by the Research Ethics Committee of the Chinese People’s Liberation Army General Hospital. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Given the observational and retrospective nature of this study, no additional informed consent was required, and the privacy of all patients was fully secured.
Financial interests
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lu, X., Chen, T., Liu, G. et al. Relations between left atrial appendage contrast retention and thromboembolic risk in patients with atrial fibrillation. J Thromb Thrombolysis 53, 191–201 (2022). https://doi.org/10.1007/s11239-021-02490-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-021-02490-8